Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ENTX
Stock Latest News
TipRanks Newswire
Entera Takes Final Step Towards Phase 3, Accelerating Timeline for First Oral Anabolic Osteoporosis Therapy
9d ago
CDXS
ENTX
Premium
TipRanks Newswire
Entera Bio Moves Toward Phase 3 With Oral Therapy That Could Transform Osteoporosis Treatment (NASDAQ: ENTX)
16d ago
AZN
IBO
Premium
Company Announcements
Entera Bio Submits Streamlined Phase 3 Plan for EB613
17d ago
8K
ENTX
Premium
The Fly
Entera Bio submits streamlined Phase 3 protocol to U.S. FDA for EB613
17d ago
ENTX
Premium
TipRanks Newswire
Entera Bio Heads Toward Phase 3 With EB613 in a 200 Million-Woman Osteoporosis Market (NASDAQ: ENTX)
26d ago
ENTX
Premium
The Fly
Entera Bio announces open market purchases of stock by board members
1M ago
ENTX
Premium
Company Announcements
Entera Bio Names Geno Germano Independent Board Chairman
1M ago
8K
ENTX
Premium
The Fly
Entera Bio appoints Geno Germano as chairman of the board
1M ago
PFE
ENTX
Premium
Company Announcements
Entera Bio Expands OPKO Partnership, Adds New Director
1M ago
8K
ENTX
Premium
The Fly
Opko Health Entera Bio, Entera Bio expand partnership to advance PTH tablet
1M ago
OPK
ENTX
Premium
The Fly
Entera Bio announces expected milestones for Q1 in 2026
2M ago
ENTX
Premium
The Fly
Entera Bio ‘congratulates’ FNIH-ASBMR-SABRE team on FDA endpoint qualification
3M ago
ENTX
Premium
The Fly
Entera Bio announces new data on long-acting PTH tablet
3M ago
ENTX
Premium
Company Announcements
Entera Bio Reports Q3 2025 Financial Results
4M ago
ENTX
Premium
Company Announcements
Entera Bio Reports Q3 2025 Results and FDA Agreement
4M ago
8K
ENTX
Premium
The Fly
Entera Bio presents clinical data from EB613 Phase 2 trial
5M ago
ENTX
Premium
Ratings
Entera Bio’s Promising Oral Therapies Drive Buy Rating: Analyst Highlights Developments in GLP-2 and EB613 Programs
6M ago
ENTX
Premium
The Fly
Entera Bio announces presentation of PK data for GLP-2 tablet treatment
6M ago
ENTX
Premium
The Fly
Entera Bio presents data on EB613 in post-menopausal women with osteoporosis
6M ago
ENTX
Premium
The Fly
Entera Bio to present data across three oral peptide programs
7M ago
ENTX
Premium
Ratings
Entera Bio’s Promising Phase 3 Study and Market Potential Drive Buy Rating
7M ago
ENTX
Premium
Company Announcements
Entera Bio Reports Q2 2025 Financial Results and Strategic Progress
7M ago
ENTX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
